09/18/2025
7:00 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2025
3:02 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2025
4:25 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2025
3:05 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2025
7:00 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2025
7:00 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2025
4:15 PM | MIRA Pharmaceuticals (Filer)
| Form DEFA14A | |
08/08/2025
4:15 PM | MIRA Pharmaceuticals (Filer)
| Form DEFM14A | |
07/29/2025
4:26 PM | MIRA Pharmaceuticals (Filer)
| Form PRER14A | |
07/28/2025
3:01 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2025
3:19 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for MIRA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
07/08/2025
4:25 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2025
6:30 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2025
3:01 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2025
7:01 AM | MIRA Pharmaceuticals (Filer)
| Form PREM14A | |
06/10/2025
6:12 AM | MIRA Pharmaceuticals (Issuer)
Weichselbaum Alan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/28/2025
7:00 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2025
4:25 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
6:30 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2025
6:30 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
6:30 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2025
4:28 PM | MIRA Pharmaceuticals (Filer)
| Form 10-K/A | |
04/16/2025
4:17 PM | MIRA Pharmaceuticals (Filer)
| Form 424B5 | |
04/16/2025
6:30 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2025
4:15 PM | MIRA Pharmaceuticals (Filer)
| Form 10-K/A | |
04/11/2025
4:15 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
6:30 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
6:30 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2025
6:45 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
7:00 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
4:00 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
7:30 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
4:15 PM | Del Giudice Matthew Paul (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:15 PM | MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:15 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:15 PM | MIRA Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:15 PM | MacPherson Edward Clouston (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:15 PM | MIRA Pharmaceuticals (Issuer)
Whalen Matthew Pratt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
7:45 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
3:15 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
4:58 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
10/21/2024
6:00 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:20 PM | MIRA Pharmaceuticals (Filer)
| Form 424B5 | |
09/27/2024
3:45 PM | MIRA Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
